Amendment to: Predicting Recurrence Risk in Resected Stage I-III Melanoma Through Circulating Tumor DNA Analysis - Quiz - MDSpire

Amendment to: Predicting Recurrence Risk in Resected Stage I-III Melanoma Through Circulating Tumor DNA Analysis

  • By

  • Mengke Zhao

  • Lianjun Zhao

  • Yueling Yang

  • Fufeng Wang

  • Jiani Yin

  • Xiaoying Wu

  • Yu Ren

  • Xinyu Su

  • Yirong Wu

  • Luqiao Li

  • Rong Huang

  • Kelin Zheng

  • JiaYu Wang

  • Zhengyun Zou

  • January 27, 2026

  • 0 min

Share

Original Source(s)

Amendment to: Predicting Recurrence Risk in Resected Stage I-III Melanoma Through Circulating Tumor DNA Analysis

  • by Mengke Zhao, Lianjun Zhao, Yueling Yang, Fufeng Wang, Jiani Yin, Xiaoying Wu, Yu Ren, Xinyu Su, Yirong Wu, Luqiao Li, Rong Huang, Kelin Zheng, JiaYu Wang, Zhengyun Zou

  • January 27, 2026

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

FOXA2 in cancer: from fundamental biology to clinical translation

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer